Brandes International Equity I holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Brandes International Equity Fund Class I BIIEX
- NAV / 1-Day Return 29.18 / +0.24 %
- Total Assets 2.6B
-
Adj. Expense Ratio
0.860%
- Expense Ratio 0.850%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 2.23%
- Turnover 30%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis BIIEX
Will BIIEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Sanofi SA | 3.09 | 82M | Healthcare |
Northern Institutional Treasury Premier | 2.81 | 74M | Cash and Equivalents |
SAP SE | 2.56 | 68M | Technology |
Alibaba Group Holding Ltd Ordinary Shares | 2.36 | 62M | Consumer Cyclical |
Takeda Pharmaceutical Co Ltd | 2.35 | 62M | Healthcare |
Henkel AG & Co KGaA | 2.25 | 60M | Consumer Defensive |
Wal - Mart de Mexico SAB de CV | 2.23 | 59M | Consumer Defensive |
Heineken Holding NV | 1.98 | 52M | Consumer Defensive |
The Swatch Group AG | 1.95 | 52M | Consumer Cyclical |
Reckitt Benckiser Group PLC | 1.89 | 50M | Consumer Defensive |